DELAXIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Delaxin, and what generic alternatives are available?
Delaxin is a drug marketed by Ferndale Labs and is included in one NDA.
The generic ingredient in DELAXIN is methocarbamol. There are twenty-seven drug master file entries for this compound. Sixty-two suppliers are listed for this compound. Additional details are available on the methocarbamol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Delaxin
A generic version of DELAXIN was approved as methocarbamol by PRINSTON INC on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DELAXIN?
- What are the global sales for DELAXIN?
- What is Average Wholesale Price for DELAXIN?
Summary for DELAXIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 105 |
| Patent Applications: | 3,585 |
| DailyMed Link: | DELAXIN at DailyMed |
US Patents and Regulatory Information for DELAXIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferndale Labs | DELAXIN | methocarbamol | TABLET;ORAL | 085454-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
